18FDG-PET-CT: An imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals

Stroke

Volumn 45, Issue 12, 2014, Pages 3561-3566

  Müller, Hubertus Fritz Georg ^a   Viaccoz, Aurélien ^a   Fisch, Loraine ^a   Bonvin, Christophe ^b   Lovblad, Karl Olof ^a   Ratib, Osman ^a   Lalive, Patrice ^a   Pagano, Sabrina ^a   Vuilleumier, Nicolas ^a   Willi, Jean Pierre ^a   Sztajzel, Roman ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hopital de Sion   (Switzerland)

Author keywords

Brain imaging; Carotid plaque; Carotid stenosis; Imaging; Stroke; Vascular occlusion

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLOPIDOGREL; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG MEGADOSE; DRUG UPTAKE; FEMALE; HIGH RISK PATIENT; HUMAN; JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; NEUROIMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; TRANSCRANIAL DOPPLER; VERY ELDERLY; AREA UNDER THE CURVE; CAROTID STENOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DOPPLER ECHOGRAPHY; INTRACRANIAL EMBOLISM; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CAROTID STENOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84922480627     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006488     Document Type: Article

References (39)

1. North American Symptomatic Carotid Endarterectomy Trial collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Eng J Med. 1991;325:445-453.
2. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterctomy in patients with symptomatic moderate or severe stenosis. N Eng J Med. 1998;339:1415-1425.
3. Naylor AR, Rothwell PM, Bell PR. Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg. 2003;26:115-129.
4. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045-2051.
5. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13-C18.
6. Yazdani SK, Vorpahl M, Ladich E, Virmani R. Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke. Curr Treat Options Cardiovasc Med. 2010;12:297-314.
7. Marnane M, Prendeville S, McDonnell C, Noone I, Barry M, Crowe M, et al. Plaque inflammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis. Stroke. 2014;45:801-806.
8. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke. 2000;31:774-781.
9. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
10. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms. Circulation. 2006;113:2320-2328.
11. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305-332.
12. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
13. Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron-emission tomography. Circulation. 2002;105:2708-2711.
14. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med. 1994;35:104-112.
15. Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun. 2001;22:747-753.
16. Saito H, Kuroda S, Hirata K, Magota K, Shiga T, Tamaki N, et al. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Cerebrovasc Dis. 2013;35:370-377.
17. Marnane M, Merwick A, Sheehan OC, Hannon N, Foran P, Grant T, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71: 709-718.
18. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron- emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-115.
19. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk. Stroke. 2009;40:3711-3717.
20. Ritter MA, Dittrich R, Thoenissen N, Ringelstein EB, Nabavi DG. Prevalence and prognostic impact of microembolic signals in arterial sources of embolism. J Neurol. 2008;255:953-961.
21. Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study. Lancet Neurol. 2010;9:663-671.
22. Sitzer M, Müller W, Siebler M, Hort W, Kniemeyer HW, Jäncke L, et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 1995;26:1231-1233.
23. Sztajzel R, Momjian-Mayor I, Comelli M, Momjian S. Correlation of cerebrovascular symptoms and microembolic signals with the stratified gray-scale median analysis and color mapping of the carotid plaque. Stroke. 2006;37:824-829.
24. Moustafa RR, Izquierdo-Garcia D, Fryer TD, Graves MJ, Rudd JH, Gillard JH, et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke. Circ Cardiovasc Imaging. 2010;3:536-541.
25. D e Bray JM, Glatt B. Quantification of atheromatous stenosis in the extracranial carotid artery. Cerebrovasc Dis. 1995;5:414-426.
26. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, et al. Consensus on microembolus detection by TCD. Stroke. 1998;29:725-729.
27. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. Circulation. 2005;111:2233-2240.
28. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis. Lancet Neurol. 2010;9:489-497.
29. Wijnhoud AD, Franckena M, van der Lugt A, Koudstaal PJ, Dippel ED. Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density. Ultrasound Med Biol. 2008;34:923-929.
30. Forteza AM, Babikian VL, Hyde C, Winter M, Pochay V. Effect of time and cerebrovascular symptoms of the prevalence of microembolic signals in patients with cervical carotid stenosis. Stroke. 1996;27:687-690.
31. Spence JD. Secondary stroke prevention. Nat Rev Neurol. 2010;6:477-486.
32. Bogiatzi C, Cocker MS, Beanlands R, Spence JD. Identifying high-risk asymptomatic carotid stenosis. Expert Opin Med Diagn. 2012;6:139-151.
33. Beckman JA. Management of asymptomatic internal carotid artery stenosis. JAMA. 2013;310:1612-1618.
34. Graebe M, Pedersen SF, Borgwardt L, Højgaard L, Sillesen H, Kjaer A. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg. 2009;37:714-721.
35. Kwee RM, Truijman MT, Mess WH, Teule GJ, ter Berg JW, Franke CL, et al. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol. 2011;32:950-954.
36. Li J, Liu H, Zhi G, Yin D, Wang J, Gai J, et al. [Evaluation of carotid artery plaque stability with 18F-FDG PET/CT and contrast-enhanced ultrasonography]. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32: 981-985.
37. Oliver TB, Lammie GA, Wright AR, Wardlaw J, Patel SG, Peek R, et al. Atherosclerotic plaque at the carotid bifurcation: CT angiographic appearance with histopathologic correlation. AJNR Am J Neuroradiol. 1999;20:897-901.
38. Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, et al. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection. Ann Nucl Med. 2014;28:571-579.
39. Graebe M, Borgwardt L, Højgaard L, Sillesen H, Kjaer A. When to image carotid plaque inflammation with FDG PET/CT. Nucl Med Commun. 2010;31:773-779.